Yuyu Pharma (XKRX:000220) ROCE % : 17.32% (As of Mar. 2024)

View and export this data going back to 1975. Start your Free Trial

What is Yuyu Pharma ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Yuyu Pharma's annualized ROCE % for the quarter that ended in Mar. 2024 was 17.32%.

Yuyu Pharma ROCE % Historical Data

The historical data trend for Yuyu Pharma's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuyu Pharma ROCE % Chart

Yuyu Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

8.28

4.72

1.20

-0.84

-2.07

Yuyu Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															3.72	-4.79	-4.16	-2.30	17.32

Yuyu Pharma ROCE % Calculation

Yuyu Pharma's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-2888.367	/	( ( (195205.073 - 64315.528)	+	(198213.527 - 49975.203) )	/ 2 )
	=	-2888.367	/	( (130889.545	+	148238.324)	/ 2 )
	=	-2888.367	/	139563.9345
	=	-2.07 %

Yuyu Pharma's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	26212.256	/	( ( (198213.527 - 49975.203)	+	(196710.676 - 42339.145) )	/ 2 )
	=	26212.256	/	( ( 148238.324	+	154371.531 )	/ 2 )
	=	26212.256	/	151304.9275
	=	17.32 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Yuyu Pharma (XKRX:000220) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Yuyu Pharma ROCE % Related Terms

Thank you for viewing the detailed overview of Yuyu Pharma's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Yuyu Pharma (XKRX:000220) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuyu Pharma Inc (XKRX:000220) » Definitions » ROCE %

Traded in Other Exchanges

000227.PFD:Korea 000225.PFD:Korea

Address

197, Dongho-ro, Yuyu Building, Jung-gu, Seoul, KOR

Website

http://www.yuyu.co.kr

Yuyu Pharma Inc. manufactures and markets medicines. The major product is the medicines for Alzheimer's, which accounts for 45% of total revenue. The company also engages in health aid foods, rental of oxygen generator and analysis of medicines.

Yuyu Pharma (XKRX:000220) Headlines

No Headlines